ArticlePLOS digital health2025
Predicting the onset of chronic kidney disease (CKD) for diabetic patients with aggregated longitudinal EMR data.
Article in PLOS digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Machine learning models for predicting short-term progression in patients with stage 4 chronic kidney disease: a multi-center validation study.Scientific reports · 2025Observational
- Renal Status in Newly Diagnosed Patients with Diabetes Mellitus: A Descriptive Study in Primary Care and Opportunities for Improving Management.Journal of clinical medicine · 2025Article
- Artificial intelligence in chronic disease self-management: current applications and future directions.Frontiers in public health · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic kidney disease (CKD) affects over 13% of the population, totaling more than 800 million individuals worldwide. Timely identification and intervention are crucial to delay CKD progression and improve patient outcomes. This research focuses on developing a predictive model to classify diabetic patients showing signs of kidney function impairment based on their CKD development risk. Our model utilizes electronic medical record (EMR) data, specifically by incorporating patient demographics, laboratory results, chronic conditions, risk factors, and medication codes to predict the onset of CKD in diabetic patients six months in advance, achieving an average Area Under the Curve (AUC) of 0.88. We leverage aggregated EMR data to effectively capture relevant information within the observation year instead of using temporal EMR data. Furthermore, we identify the most significant features for predicting CKD onset, including mean, minimum, and first quartile of estimated glomerular filtration rate (eGFR) during the observation year, along with variables such as diagnosis age and duration of hypertension, osteoarthritis, and diabetes, as well as levels of hemoglobin and fasting blood glucose (FBG). We also explored a refined model utilizing only these most significant features, which yields a slightly lower AUC of 0.86. These variables are typically available in primary data, empowering physicians for real-time risk assessment. The proposed model's ability to identify higher-risk patients is essential for timely intervention, personalized care, risk stratification, patient education, and potential cost savings. This research contributes valuable insights for healthcare practitioners seeking efficient tools for early CKD detection in diabetic populations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.